Status:
UNKNOWN
Stablishment of Prevention and Treatment System for Intestinal Dysfunction
Lead Sponsor:
Nanjing University School of Medicine
Conditions:
Bowel Dysfunction
Eligibility:
All Genders
18-65 years
Phase:
PHASE1
PHASE2
Brief Summary
Dysfunction and intestinal endocrine dysfunction. This project will use genomics, metabonomics, microbiome and other omics techniques to study the clinical pathway of CID integrated therapy.
Eligibility Criteria
Inclusion
- The Patients with chronic bowel dysfunction
Exclusion
- Past severe underlying diseases of the respiratory system and cardiovascular system,
- Allergy to treatment-related drugs,
- Pregnancy,
- Accept CID surgery.
Key Trial Info
Start Date :
October 1 2020
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
September 30 2023
Estimated Enrollment :
50 Patients enrolled
Trial Details
Trial ID
NCT04507945
Start Date
October 1 2020
End Date
September 30 2023
Last Update
August 11 2020
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.